PL378405A1 - Pochodne malonoamidu jako inhibitory <$Egamma> - sekretazy - Google Patents

Pochodne malonoamidu jako inhibitory <$Egamma> - sekretazy

Info

Publication number: PL378405A1
Authority: PL; Poland
Prior art keywords: gamma; secretase inhibitors; malonamide derivatives; malonamide; derivatives
Prior art date: 2003-02-04

Application number

PL378405A

Other languages

English (en)

Inventor

Guido Galley

Annick Goergler

Helmut Jacobsen

Eric Argirios Kitas

Jens-Uwe Peters

Original Assignee

F. Hoffmann-La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-04

Filing date

2004-01-27

Publication date

2006-04-03

2004-01-27 Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag

2006-04-03 Publication of PL378405A1 publication Critical patent/PL378405A1/pl

Links

239000003540 gamma secretase inhibitor Substances 0.000 title 1
WRIRWRKPLXCTFD-UHFFFAOYSA-N malonamide Chemical class NC(=O)CC(N)=O WRIRWRKPLXCTFD-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Indole Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

PL378405A 2003-02-04 2004-01-27 Pochodne malonoamidu jako inhibitory <$Egamma> - sekretazy PL378405A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03002190		2003-02-04

Publications (1)

Publication Number	Publication Date
PL378405A1 true PL378405A1 (pl)	2006-04-03

Family

ID=32842686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL378405A PL378405A1 (pl)	2003-02-04	2004-01-27	Pochodne malonoamidu jako inhibitory <$Egamma> - sekretazy

Country Status (23)

Country	Link
US (1)	US7375099B2 (pl)
EP (1)	EP1592684B1 (pl)
JP (1)	JP4662914B2 (pl)
KR (1)	KR100810810B1 (pl)
CN (1)	CN100480248C (pl)
AR (1)	AR042996A1 (pl)
AT (1)	ATE402934T1 (pl)
BR (1)	BRPI0407262A (pl)
CA (1)	CA2514267C (pl)
CL (1)	CL2004000174A1 (pl)
CO (1)	CO5580761A2 (pl)
DE (1)	DE602004015415D1 (pl)
ES (1)	ES2311795T3 (pl)
HR (1)	HRP20050663A2 (pl)
IL (1)	IL169691A (pl)
MX (1)	MXPA05008172A (pl)
NO (1)	NO20053627L (pl)
NZ (1)	NZ541324A (pl)
PL (1)	PL378405A1 (pl)
RU (1)	RU2330849C2 (pl)
TW (1)	TWI293070B (pl)
WO (1)	WO2004069826A1 (pl)
ZA (1)	ZA200506212B (pl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521481B2 (en)	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
EA009940B1 (ru) *	2003-09-09	2008-04-28	Ф. Хоффманн-Ля Рош Аг	ПРОИЗВОДНЫЕ МАЛОНАМИДА, БЛОКИРУЮЩИЕ АКТИВНОСТЬ γ-СЕКРЕТАЗЫ
CN1894217B (zh) *	2003-10-06	2011-09-21	弗·哈夫曼-拉罗切有限公司	用作γ-分泌酶抑制剂的取代的二苯并氮杂和苯并二氮杂
US7211573B2 (en)	2004-12-08	2007-05-01	Hoffmann-La Roche Inc.	Malonamide derivatives
WO2006115845A1 (en)	2005-04-20	2006-11-02	Merck & Co., Inc.	Benzothiophene derivatives
TWI417095B (zh)	2006-03-15	2013-12-01	Janssen Pharmaceuticals Inc	１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
MX2008012136A (es)	2006-03-27	2008-10-03	Hoffmann La Roche	Derivados de malonamida como inhibidores de gama secretasa.
AU2007299129A1 (en)	2006-09-20	2008-03-27	F. Hoffmann-La Roche Ag	4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
US9126987B2 (en)	2006-11-30	2015-09-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase
JP2010517954A (ja) *	2007-02-02	2010-05-27	エフ．ホフマン−ラロシュアーゲー	６−オキソ−６，７−ジヒドロ−５Ｈ−ジベンゾ［ｂ，ｄ］アゼピン−７−イル誘導体
JP5930573B2 (ja)	2007-03-01	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤の新規使用
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
JP5667440B2 (ja)	2007-04-18	2015-02-12	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
US7579464B2 (en) *	2007-05-25	2009-08-25	Hoffmann-La Roche Inc.	Process for preparation of enantiomerically pure compounds
WO2009033702A1 (en)	2007-09-14	2009-03-19	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
PL2203439T3 (pl)	2007-09-14	2011-06-30	Addex Pharmaceuticals Sa	1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony
CA2698929C (en)	2007-09-14	2016-01-19	Addex Pharma S.A.	1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
US8785486B2 (en)	2007-11-14	2014-07-22	Janssen Pharmaceuticals, Inc.	Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
ES2439291T3 (es)	2008-09-02	2014-01-22	Janssen Pharmaceuticals, Inc.	Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
MX2011003691A (es)	2008-10-16	2011-09-06	Ortho Mcneil Janssen Pharm	Derivados de indol y benzomorfolina como moduladores de los receptores de glutamato metabotropico.
ES2401691T3 (es)	2008-11-28	2013-04-23	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato
JP5634506B2 (ja)	2009-05-12	2014-12-03	ジャンセンファーマシューティカルズ，インコーポレイテッド	１，２，３−トリアゾロ［４，３−ａ］ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用
AU2010246607B2 (en)	2009-05-12	2012-09-27	Addex Pharma S.A.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
PL2475428T3 (pl)	2009-09-11	2015-12-31	Probiodrug Ag	Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
US20110190269A1 (en) *	2010-02-01	2011-08-04	Karlheinz Baumann	Gamma secretase modulators
EP2542549B1 (en)	2010-03-03	2016-05-11	Probiodrug AG	Inhibitors of glutaminyl cyclase
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
US8541596B2 (en)	2010-04-21	2013-09-24	Probiodrug Ag	Inhibitors
JP5852666B2 (ja)	2010-11-08	2016-02-03	ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド	１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2552455T3 (es)	2010-11-08	2015-11-30	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852665B2 (ja)	2010-11-08	2016-02-03	ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド	１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
US8530670B2 (en)	2011-03-16	2013-09-10	Probiodrug Ag	Inhibitors
TWI530489B (zh)	2011-03-22	2016-04-21	必治妥美雅史谷比公司	雙（氟烷基）－１，４－苯二氮呯酮化合物
JO3148B1 (ar)	2011-07-27	2017-09-20	Lilly Co Eli	مركب مثبط لإشارات مسار notch
US20150218103A1 (en) *	2012-08-25	2015-08-06	The Johns Hopkins University	Gapdh cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness
JP2015533811A (ja)	2012-09-21	2015-11-26	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｎ−置換ビス（フルオロアルキル）１，４−ベンゾジアゼピノン化合物
EP2897954B1 (en)	2012-09-21	2016-10-26	Bristol-Myers Squibb Company	Fluoroalkyl-1,4-benzodiazepinone compounds
US9427442B2 (en)	2012-09-21	2016-08-30	Bristol-Myers Squibb Company	Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
US9249157B2 (en)	2012-09-21	2016-02-02	Bristol-Myers Squibb Company	Tricyclic heterocycle compounds
TWI614238B (zh)	2012-09-21	2018-02-11	必治妥美雅史谷比公司	雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
CN104968648A (zh)	2012-09-21	2015-10-07	百时美施贵宝公司	1,4-苯并二氮杂*酮化合物的前药
EP2897944B1 (en)	2012-09-21	2016-10-26	Bristol-Myers Squibb Company	Substituted 1,5-benzodiazepinone compounds
JP2015534554A (ja)	2012-09-21	2015-12-03	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	アルキル，フルオロアルキル−１，４−ベンゾジアゼピノン化合物
US9133126B2 (en)	2012-09-21	2015-09-15	Bristol-Myers Squibb Company	Fluoroalkyl dibenzoazepinone compounds
CN105101968A (zh)	2013-04-04	2015-11-25	百时美施贵宝公司	治疗增殖性疾病的组合疗法
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20200036063A (ko)	2014-01-21	2020-04-06	얀센 파마슈티카 엔.브이.	대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
KR20220038826A (ko)	2014-01-21	2022-03-29	얀센 파마슈티카 엔.브이.	대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
ES2812698T3 (es)	2017-09-29	2021-03-18	Probiodrug Ag	Inhibidores de glutaminil ciclasa
NO20200333A1 (en) *	2020-03-20	2021-03-29	Axichem As	Synthesis of capsaicin derivatives
EP4185306A4 (en) *	2020-07-23	2024-11-06	Purdue Research Foundation	NOTCH SIGNAL INHIBITORS FOR THE TREATMENT OF OBESITY AND METABOLIC DISEASES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS597193A (ja) *	1982-07-02	1984-01-14	Shionogi & Co Ltd	マロニルメチル基の異性化方法
US4968678A (en) *	1988-02-19	1990-11-06	Eli Lilly And Company	Tetrazole excitatory amino acid receptor antagonists
WO1993003011A1 (fr) *	1991-08-08	1993-02-18	Yamanouchi Pharmaceutical Co., Ltd.	Derive d'uree
AU7997700A (en) *	1999-10-08	2001-04-23	Du Pont Pharmaceuticals Company	Amino lactam sulfonamides as inhibitors of abeta protein production
WO2001074783A1 (en) *	2000-04-03	2001-10-11	Dupont Pharmaceuticals Company	Cyclic lactams as inhibitors of a βετα protein production
WO2001077086A1 (en)	2000-04-11	2001-10-18	Dupont Pharmaceuticals Company	SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
EA009940B1 (ru) *	2003-09-09	2008-04-28	Ф. Хоффманн-Ля Рош Аг	ПРОИЗВОДНЫЕ МАЛОНАМИДА, БЛОКИРУЮЩИЕ АКТИВНОСТЬ γ-СЕКРЕТАЗЫ

2004
- 2004-01-27 KR KR1020057014244A patent/KR100810810B1/ko not_active Expired - Fee Related
- 2004-01-27 AT AT04705404T patent/ATE402934T1/de active
- 2004-01-27 DE DE602004015415T patent/DE602004015415D1/de not_active Expired - Lifetime
- 2004-01-27 PL PL378405A patent/PL378405A1/pl not_active Application Discontinuation
- 2004-01-27 HR HR20050663A patent/HRP20050663A2/xx not_active Application Discontinuation
- 2004-01-27 NZ NZ541324A patent/NZ541324A/en unknown
- 2004-01-27 BR BR0407262-6A patent/BRPI0407262A/pt not_active IP Right Cessation
- 2004-01-27 WO PCT/EP2004/000674 patent/WO2004069826A1/en not_active Ceased
- 2004-01-27 JP JP2006500017A patent/JP4662914B2/ja not_active Expired - Fee Related
- 2004-01-27 CA CA2514267A patent/CA2514267C/en not_active Expired - Fee Related
- 2004-01-27 RU RU2005127666/04A patent/RU2330849C2/ru not_active IP Right Cessation
- 2004-01-27 EP EP04705404A patent/EP1592684B1/en not_active Expired - Lifetime
- 2004-01-27 ES ES04705404T patent/ES2311795T3/es not_active Expired - Lifetime
- 2004-01-27 CN CNB2004800033052A patent/CN100480248C/zh not_active Expired - Fee Related
- 2004-01-27 MX MXPA05008172A patent/MXPA05008172A/es active IP Right Grant
- 2004-01-29 US US10/767,784 patent/US7375099B2/en not_active Expired - Fee Related
- 2004-01-30 TW TW093102218A patent/TWI293070B/zh active
- 2004-02-02 AR ARP040100306A patent/AR042996A1/es not_active Application Discontinuation
- 2004-02-02 CL CL200400174A patent/CL2004000174A1/es unknown
2005
- 2005-07-14 IL IL169691A patent/IL169691A/en not_active IP Right Cessation
- 2005-07-25 CO CO05072813A patent/CO5580761A2/es not_active Application Discontinuation
- 2005-07-26 NO NO20053627A patent/NO20053627L/no not_active Application Discontinuation
- 2005-08-03 ZA ZA200506212A patent/ZA200506212B/en unknown

Also Published As

Publication number	Publication date
IL169691A0 (en)	2007-07-04
DE602004015415D1 (de)	2008-09-11
HRP20050663A2 (en)	2006-12-31
MXPA05008172A (es)	2005-10-05
AU2004210036A1 (en)	2004-08-19
CL2004000174A1 (es)	2005-01-14
JP4662914B2 (ja)	2011-03-30
EP1592684B1 (en)	2008-07-30
NZ541324A (en)	2008-10-31
CA2514267C (en)	2011-05-17
US20040220222A1 (en)	2004-11-04
AR042996A1 (es)	2005-07-13
JP2006516556A (ja)	2006-07-06
EP1592684A1 (en)	2005-11-09
CA2514267A1 (en)	2004-08-19
IL169691A (en)	2011-03-31
BRPI0407262A (pt)	2006-01-31
KR20050105452A (ko)	2005-11-04
CO5580761A2 (es)	2005-11-30
ATE402934T1 (de)	2008-08-15
ZA200506212B (en)	2006-05-31
ES2311795T3 (es)	2009-02-16
WO2004069826A1 (en)	2004-08-19
TWI293070B (en)	2008-02-01
CN1745076A (zh)	2006-03-08
KR100810810B1 (ko)	2008-03-06
NO20053627L (no)	2005-08-10
RU2330849C2 (ru)	2008-08-10
TW200423928A (en)	2004-11-16
US7375099B2 (en)	2008-05-20
RU2005127666A (ru)	2006-04-27
CN100480248C (zh)	2009-04-22

Legal Events

Date	Code	Title	Description
2013-08-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL169691A0 (en)	2007-07-04	Malonamide derivatives as gamma-secretase inhibitors
SI1492785T1 (sl)	2009-06-30	2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3
PL370478A1 (pl)	2005-05-30	Pochodne aminoindazolu jako inhibitory kinaz białkowych
AP2048A (en)	2009-09-24	Diazepinoindole derivatives as kinase inhibitors
ZA200702394B (en)	2008-11-26	Indozolone derivatives as 11b-HSD1 inhibitors
PL1635840T3 (pl)	2009-01-30	Tiofenopirymidynony jako inhibitory dehydrogenazy 17-beta-hydroksysteroidowej
ZA200700181B (en)	2009-03-25	Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
EP1551801A4 (en)	2007-06-20	NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
IL176554A0 (en)	2006-10-31	Thiophene derivatives as chk 1 inhibitors
IL192053A0 (en)	2008-12-29	2-adamantylurea derivatives as selective 11??-hsd1 inhibitors
IL172132A0 (en)	2006-04-10	Thienopyridone derivatives as kinase inhibitors
IL183293A0 (en)	2007-09-20	Malonamide derivatives
IL165887A0 (en)	2006-01-15	Novel tetrahydropyridine derivatives as renin inhibitors
IL174513A0 (en)	2006-08-01	Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors
IL172375A0 (en)	2009-02-11	Chinazoline derivatives as aurora kinase inhibitors
IL175106A0 (en)	2006-09-05	Novel keto-oxadiazole derivatives as cathepsin inhibitors
PL377124A1 (pl)	2006-01-23	Pochodne oksamidu użyteczne jako inhibitory kinazy raf
IL172793A0 (en)	2006-06-11	Nicotinamide derivatives useful as pde4 inhibitors
GB0317516D0 (en)	2003-08-27	Nicotinamide derivatives useful as PDE4 inhibitors
GB0317484D0 (en)	2003-08-27	Nicotinamide derivatives useful as pde4 inhibitors
GB0317482D0 (en)	2003-08-27	Nicotinamide derivatives useful as pde4 inhibitors
GB0317509D0 (en)	2003-08-27	Nicotinamide derivatives useful as PDE4 inhibitors
GB0317472D0 (en)	2003-08-27	Nicotinamide derivatives useful as PDE4 inhibitors
AU2003232362A8 (en)	2003-12-22	4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
PL376540A1 (pl)	2006-01-09	Pochodne diazepanów stosowane jako inhibitory LFA